🕵️ ABVC Biopharma, Inc. ($ABVC)
SEC insider & ownership activity, last 12 months · CIK 1173313 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Eugene Jiang added 17.4% → 18.5%. One red-flag 8-K in the window: Restatement (4.02), Mar 3, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Eugene Jiang | 18.5% | 13D | Jul 10, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Auditor change (4.01) | Jul 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 2, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Earnings (2.02) | Mar 3, 2026 | filing ↗ |
| Restatement (4.02) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Earnings (2.02) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |
| Earnings (2.02) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2025 | filing ↗ |
| Auditor change (4.01) | Oct 18, 2024 | filing ↗ |